Kidney transplant evaluation: why there are many steps

Understanding the evaluation

A kidney transplant places a working donor kidney into a person whose own kidneys can no longer clear the body's waste and fluid adequately. Before that can safely happen, the transplant team needs to answer a series of separate safety questions: is your heart strong enough for the operation and the years of medicine that follow; is there any hidden infection or cancer that immunosuppression could make dangerous; is your blood vessel anatomy suitable; are you and a potential donor compatible; can you take anti-rejection medicines reliably for life; and do you have the support to attend follow-up indefinitely. Evaluation is the structured process of answering each of those questions — it is not the transplant itself, and not everyone who starts it ends up needing every step.

It helps to understand why the heart features so heavily in this process. Kidney failure and cardiovascular disease share many of the same drivers — high blood pressure, diabetes and years of strain on blood vessels — so a patient reaching transplant evaluation very often has some degree of heart involvement already, whether or not it has caused symptoms. Surgery and the fluid shifts of the transplant itself place real demand on the heart, which is why cardiovascular assessment is a core, not optional, part of transplant work-up.

When evaluation is recommended

Evaluation is usually recommended once kidney failure is advanced enough that transplant is a realistic option, whether or not dialysis has already started. Common starting points include:

• ●Advanced chronic kidney disease approaching the point where dialysis or transplant will be needed
• ●Kidney failure already requiring dialysis, where transplant may reduce the burden of ongoing treatment
• ●Interest in a living-donor pathway, where a family member or other willing donor is being considered
• ●A need for formal cardiovascular clearance before a transplant date can be confirmed
• ●Questions about medicines, costs, timelines and lifelong follow-up before deciding whether to proceed

How the evaluation is organised, step by step

The exact order and combination of steps depends on your health, but a full evaluation typically works through the following:

• 01
  Nephrology and transplant-surgery review. A detailed history and examination, and an early discussion of what transplant would realistically mean for you.
• 02
  Cardiovascular assessment. Because kidney failure and heart disease so often coexist, this typically includes an ECG, an echocardiogram and, where indicated, further heart testing to confirm you can safely tolerate surgery and years of transplant medicines.
• 03
  Blood group and tissue typing. Determines compatibility with a potential donor and, for deceased-donor waiting lists, how closely a future donor kidney needs to match.
• 04
  Infection screening. Checks for infections that immunosuppression could reactivate or worsen, so they can be treated or monitored beforehand rather than discovered after transplant.
• 05
  Cancer screening appropriate to your age and risk. Immunosuppression can allow an undetected cancer to progress faster, so age-appropriate screening is completed first.
• 06
  General health and other-organ review. Lung, liver and diabetes assessment as relevant, since these affect surgical risk and medicine choices.
• 07
  Psychosocial assessment. A conversation about support at home, understanding of lifelong medicines, and readiness for the follow-up commitment — this protects you, not just the programme.
• 08
  Donor assessment, where relevant. A potential living donor undergoes their own separate, voluntary medical and psychological evaluation, with an outcome that is never shared with the recipient without the donor's consent.

Some steps run in parallel rather than strictly in sequence, which is why evaluation can feel like many appointments arriving close together rather than one single visit.

Living-donor and deceased-donor pathways

These two routes differ in timing and process, and it is worth understanding both even if only one applies to you.

Living donation

A willing, medically suitable relative or other donor can potentially donate a kidney sooner than waiting for a deceased donor, and living-donor kidneys often function well for a long time. The donor's own health always comes first: their evaluation is independent, thorough and entirely voluntary, and they can withdraw at any point without having to explain why.

Deceased donation

Where no suitable living donor is available, a patient is placed on a waiting list matched by blood group, tissue type and clinical need; waiting times vary and cannot be predicted for an individual.

Factors that can affect the evaluation pathway

These do not automatically prevent transplant, but they shape how evaluation is approached and what needs closer attention:

• ●Longstanding high blood pressure or diabetes — very common causes of kidney failure in Nigeria, and relevant to cardiovascular risk during evaluation
• ●Existing heart or blood vessel disease
• ●Obesity, which can affect surgical risk and is often addressed as part of preparation
• ●Active or untreated infection
• ●Smoking
• ●Limited social or family support for the lifelong follow-up transplant requires
• ●Difficulty affording lifelong anti-rejection medicines, which is why costs and HMO or insurance cover are discussed early, not left until after surgery

Why thoroughness matters

Evaluation can feel slow, but each step exists to prevent a specific, foreseeable problem later.

Missed cardiovascular risk. Undetected heart disease is a leading cause of serious complications around the time of transplant surgery, which is why cardiac clearance is treated as essential rather than a formality.

Undetected infection. An infection that would normally be manageable can become serious once immunosuppression begins, so screening and treatment beforehand meaningfully lowers this risk.

Poor donor-recipient matching. Skipping or rushing compatibility testing raises the risk of early rejection of the transplanted kidney.

Unpreparedness for lifelong follow-up. A kidney can be lost to preventable rejection when medicines are missed or follow-up is not maintained — the psychosocial assessment exists to identify and address this risk before it happens, not to judge.

What happens once evaluation is complete

Once the required steps are finished, the transplant team reviews the full picture together. Outcomes vary: some patients proceed directly with an identified living donor; some are placed on a waiting list; some need a specific issue treated or stabilised first before proceeding; and occasionally the team advises that transplant is not the safest option at that time, with alternatives discussed openly.

Making the most of the evaluation period

• ✓Attend every planned assessment, even ones that feel repetitive — each answers a different question
• ✓Keep a complete, up-to-date list of medicines and previous records
• ✓Continue dialysis and existing treatment exactly as prescribed throughout evaluation
• ✓Ask how follow-up visits and anti-rejection medicines will be maintained long after surgery, not just how the operation itself will go
• ✓Involve a trusted support person in appointments and education — transplant follow-up works best as a shared effort

Preparing for your appointment

What to bring

• ✓A complete list of medicines, including herbal and over-the-counter products
• ✓Previous dialysis, kidney and cardiac records
• ✓Details of any potential living donor already identified
• ✓Your HMO card or payment details

What we will ask

Your kidney disease history, current dialysis pattern if applicable, other medical conditions, support at home, and your understanding of what lifelong transplant follow-up involves.

Questions worth asking us

• ●Which steps of evaluation apply to me, and in what order?
• ●What would make me unsuitable for transplant, and could that change with treatment?
• ●How does a living-donor option change my timeline compared with waiting?
• ●What will lifelong follow-up and medicine costs realistically look like?